RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
NCT06121297
This study is recruiting at 18 US sites in 12 states, according to its ClinicalTrials.gov record last updated .
Summary
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Systemic Lupus Erythematosus
- Lupus Nephritis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 12 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Cabaletta Bio
- Last updated on ClinicalTrials.gov
- October 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- University of California Irvine · Orange, CA
- UC Davis Health · Sacramento, CA
Florida · 1
- Mayo Clinic · Jacksonville, FL
Georgia · 1
- Emory University · Atlanta, GA
Illinois · 2
- Northwestern Memorial Hospital · Chicago, IL
- The University of Chicago Medical Center - Accepting Adult and Adolescent Patients · Chicago, IL
Kansas · 1
- University of Kansas Medical Center · Kansas City, KS
Massachusetts · 5
- Boston Children's Hospital - Accepting Young Adult and Adolescent Patients · Boston, MA
- Brigham and Women's Hospital · Boston, MA
- Massachusetts General Hospital · Boston, MA
- Tufts Medical Center · Boston, MA
- UMass Memorial Hospital · Worcester, MA
Minnesota · 1
- University of Minnesota · Minneapolis, MN
New York · 1
- University of Rochester · Rochester, NY
North Carolina · 1
- UNC Chapel Hill · Chapel Hill, NC
Pennsylvania · 1
- Children's Hospital of Philadelphia - Accepting Young Adult and Adolescent Patients · Philadelphia, PA
South Carolina · 1
- Medical University of South Carolina · Charleston, SC
Texas · 1
- University of Texas MD Anderson Cancer Center · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.